Drugs / Dendritic Cell/Tumor Fusion Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04388033 | Dec 2020 → Dec 2022 | glioblastoma | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell/Tumor Fusion Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04388033 ↗ |
| Modality | Vaccine | “investigational Dendritic and Glioma Cells Fusion vaccine” NCT04388033 ↗ |